PDE4抑制出现代谢障碍的TX
(健康天) - 抑制磷酸二磷酸二磷酸酯酶-4(PDE4),其水解环状腺苷(CAMP),可用于治疗代谢障碍,根据可能的研究,可用于治疗代谢障碍肥胖评论。
Noting that PDE4 activity is tightly controlled by post-translational regulation, structure-based auto-regulation, and locus specific compartmentalization with its interactive proteins (signalsomes) in order to regulate cAMP levels and signaling, Chaoneng Wu, M.D., and Sanjay Rajagopalan, M.B.B.S., from the University of Maryland School of Medicine in Baltimore, discuss the role of PDE4 inhibition as a therapeutic strategy for代谢障碍。
研究人员发现,PDE4-camp信号传导的紊乱代表了代谢障碍的病理物质相关途径,在炎症,葡萄糖无序和葡萄糖中看到关键作用脂质代谢那肝脏脂肪变性,异常脂肪解,抑制的热函数和含含衰变的神经内分泌功能。目前正在评估PDE4抑制剂以治疗疾病,如2型糖尿病和非酒精脱脂肝炎。
“靶向单独的PDE4变体的新型PDE4变构抑制剂的发现和赋状的基于态度的策略可以允许PDE4同种型选择性抑制,这可能为代谢障碍的慢性治疗提供更安全的策略,”作者写道。
进一步探索
版权所有©2016.健康天。版权所有。
用户评论